Chemoinformaics analysis of isopongaflavone/candidin
Molecular Weight | 334.371 | nRot | 2 |
Heavy Atom Molecular Weight | 316.227 | nRig | 23 |
Exact Molecular Weight | 334.121 | nRing | 4 |
Solubility: LogS | -5.75 | nHRing | 2 |
Solubility: LogP | 5.097 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 4 | No. of Arom Bond | 17 |
nHA | 4 | APOL | 50.2803 |
nHD | 0 | BPOL | 24.1337 |
QED | 0.684 |
Synth | 2.647 |
Natural Product Likeliness | 1.933 |
NR-PPAR-gamma | 0.926 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 1 |
Pgp-sub | 0 |
HIA | 0.01 |
CACO-2 | -4.657 |
MDCK | 0.0000165 |
BBB | 0.027 |
PPB | 0.94433 |
VDSS | 0.59 |
FU | 0.0423412 |
CYP1A2-inh | 0.909 |
CYP1A2-sub | 0.767 |
CYP2c19-inh | 0.933 |
CYP2c19-sub | 0.181 |
CYP2c9-inh | 0.915 |
CYP2c9-sub | 0.891 |
CYP2d6-inh | 0.669 |
CYP2d6-sub | 0.737 |
CYP3a4-inh | 0.794 |
CYP3a4-sub | 0.259 |
CL | 3.19 |
T12 | 0.181 |
hERG | 0.034 |
Ames | 0.609 |
ROA | 0.326 |
SkinSen | 0.47 |
Carcinogencity | 0.891 |
EI | 0.085 |
Respiratory | 0.943 |
NR-Aromatase | 0.929 |
Antiviral | Yes |
Prediction | 0.833183 |